BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 24, 2017, 12:33 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 24, 2017, 12:33 PM UTC
BusinessPositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics MarketBy Nasdaq OMXMay 24, 2017, 12:33 PM UTC
BusinessPositiveID Updates Report for its Molecular Diagnostics, Mobile Labs and Medical Device Businesses with Addressable Markets Exceeding $30 BillionBy Nasdaq OMXApr 24, 2017, 12:31 PM UTC
BusinessPositiveID Updates Report for its Molecular Diagnostics, Mobile Labs and Medical Device Businesses with Addressable Markets Exceeding $30 BillionBy Nasdaq OMXApr 24, 2017, 12:31 PM UTC
BusinessPositiveID Corporation to Present at RedChip’s Global Online Growth ConferenceBy Nasdaq OMXJan 25, 2017, 1:30 PM UTC
BusinessPositiveID Successfully Detects GMOs on its Firefly Dx Prototype in Pilot Study with seqIDBy Nasdaq OMXDec 12, 2016, 1:30 PM UTC
BusinessPositiveID Corporation Publishes White Paper and Data on its Successful Detection of Zika VirusBy Nasdaq OMXNov 16, 2016, 1:30 PM UTC
